USANA Health Sciences USNA Rise — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's rise — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's rise — operating income (loss)?
- USANA Health Sciences (USNA) reported rise — operating income (loss) of -$1.77M in Q1 2026.
- What does rise — operating income (loss) mean?
- Calculated as the net sales of the Rise segment minus its cost of sales, brand partner incentives, and allocated operating expenses. This metric serves as the primary indicator of the segment's core operational profitability and financial health.